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Abstract 
Post-translational modifications of histone proteins are essential to the regulation of chromatin 
structure and DNA accessibility in the eukaryotic cell.  The ability to prepare synthetic, 
chemically-modified histone proteins has enabled fundamental insights into the functions of 
histone post-translational modifications. However, these powerful chemical approaches 
inherently limit studies to an in vitro context which lacks the complexity of native biological 
systems. Here we develop tools to introduce exogenous, chemically-synthesized histones into 
different eukaryotic cell lines for assembly into chromatin in the cell nucleus.  
Previous studies have demonstrated successful uptake of recombinant H2A/H2B dimer and 
H32/H42 tetramer into the nuclei of Physarum polycephalum, a myxomycete slime mold. We 
repeat these results and extend them to show uptake of histones into a common air-borne mold of 
the Mucor genus, rat IEC cells, and human breast cancer MDA-231 cells. We demonstrate 
nuclear import of exogenous fluorescently-labeled histones into multiple cell lines through gel 
electrophoresis of isolated nuclei. Preliminary fluorescent microscopy experiments support the 
colocalization of DNA and fluorescently-labeled exogenous histones in live and in fixed cells. 
Avidin pull-downs of intact nucleosomes after uptake of biotin-labeled histone dimer indicate 
incorporation of these histones into chromatin. Our results suggest that certain histone proteins 
display cell penetrating characteristics, which may provide a method for the study of 
homogenous semi- or fully-synthetic chemically-modified histones within the complex systems 
of eukaryotic cells.  
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Chapter 1: Introduction 
Eukaryotic DNA is organized into chromatin in the nucleus. The basic unit of chromatin is the 
nucleosome, composed of ~147 bp of DNA wrapped around a protein core of histones. This core 
consists of two copies each of H2A, H2B, H3, and H4 (Fig. 1  ). The structure of the nucleosome 
regulates chromatin structure and DNA accessibility and therefore plays an important role in 
DNA transcription, translation, and replication. Nucleosome structure is regulated in part by 
post-translational modifications (PTMs) to histone proteins that alter interactions between 
histones and DNA as well as between the histones themselves, causing a multitude of changes 
such as loss of DNA-histone affinity and instability of the nucleosome core (1).  
Figure 1. Structure of the nucleosome. Red: H2A, Orange: H2B, Green; H3, Blue; H4, Gray: 
DNA. The entry/exit and dyad regions are labeled. 
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Histone Modifications 
Many different types of histone modifications have been found in nature, including 
phosphorylation, methylation, and acetylation. The function of each modification depends 
heavily upon where it is in the nucleosome. PTMs in the histone core (see Fig. 1) alter histone-
histone interactions that often destabilize the nucleosome. This can cause the nucleosome to 
unfold and increase the potential of first the H2A/H2B dimers and then the H3/H4 tetramer to 
dissociate from the DNA (2). Modifications in the entry/exit region can regulate wrapping and 
unwrapping of DNA around the nucleosome and therefore can allow partial access to the DNA 
which is important for the removal or shifting of core histone proteins (3). PTMs in the dyad 
region alter histone-DNA affinity as well and influence nucleosome sliding, a process that does 
not disassemble the nucleosome but rather slides the core histones along the DNA (3, 4). PTMs 
can further regulate the cell’s function by modulating interactions with other types of proteins 
such as transcription factors or polymerases by serving as platforms for binding (5). 
Sets of modifications tend to appear in context-dependent patterns, leading to the hypothesis that 
each modification or group of modifications has a function that helps to modulate the local 
environment around the modifications to specifically regulate DNA processes (6). DNA-related 
and histone-modifying enzymes show specificity for certain types of modifications to specific 
histone residues (5). Also, isolated histones tend to contain conserved sets of modifications. For 
example, serine 1 of histone H4 is generally acetylated. In newly-synthesized H4, lysines 5 and 
12 in the N-terminal tail are acetylated. These acetylations have been further connected to 
acetylation at lysine 91 in the histone-chaperone complex that deposits histone proteins into 
chromatin (7).  
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Studying Post-translational Modifications 
The study of modified histones poses an interesting problem since it requires homogeneously-
modified proteins. In vivo, enzymes such as histone acetyltransferases, deacetylases, 
phosphatases, methyltransferases specifically modify histone proteins (6, 8); however, use of 
these enzymes to modify histones in vitro presents multiple problems. While histone-modifying 
enzymes appear to act with some specificity in a cellular environment, this same site specificity 
is often lacking in vitro. This lack of specificity results not only in modifications at undesirable 
sites but in a failure to control the extent of modification (9). Furthermore, modifying enzymes 
have been studied to different extents, and a full set of isolated enzymes that can create all sets of 
modifications does not exist (10).  
Some recombinant modified histones can be expressed through amber codon suppression or with 
modification mimics, but these techniques are limited. First of all, expression by amber codon 
suppression requires significant bioengineering such as the creation of transgenic cell lines that 
will encode non-natural tRNAs and amino acid tRNA synthetases. Successful amber codon 
expression has been shown in eukaryotic cells, including mammalian cultures (11, 12), but the 
bulk of this expression is accomplished in prokaryotic systems, which do not have histones. 
Expression of the mutant proteins also results in smaller yields than are observed with the wild 
type variants, especially when multiple amber codon sites are used (13). Lastly, many 
modifications are currently outside the scope of amber codon suppression. Successful 
incorporation of acetyllysine, methylhistidine, and other non-canonical amino acids into proteins 
has been demonstrated in E. coli (13, 14).  Incorporation of mimics for modifications such as 
acetyllysine and methyllysine has also been shown (8); however, many modifications such as 
ubiquitination, which adds an entire protein to the histone, cannot be incorporated using this 
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method. 
Modification mimics have been used in the past to elucidate important functions of some 
modifications in the cell. The advantages to mimics are that they can often be introduced 
recombinantly and can overcome some of the drawbacks and limitations of amber codon 
suppression. Modification mimics are generally able to approximate the charge, shape, or size of 
the modified residues, though they rarely mimic every aspect of the native modification (5, 15). 
For example, both glutamine and arginine have been used to mimic acetyllysine (Fig. 2). While 
glutamine is able to approximate the charge loss caused by acetylation of the positively-charged 
lysine residue, the steric bulk is notably different. Also, though glutamine is uncharged, the end 
of its side chain is polar, and the nitrogen has a partial positive charge. Arginine, on the other 
hand, has a similar size to acetyllysine, but retains a positive charge that the acetylation removes. 
Indeed, these mimics have been shown to behave differently from the native modifications (4).  
 
 
Figure 2. Common acetyllysine mimics. Both glutamate and arginine have 
been used to mimic acetyllysine with varying degrees of success. 
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Chemical Protein Synthesis 
Our laboratory has pioneered in the synthesis of full-length modified histone proteins.  Our main 
approach is chemical synthesis of modified peptides and ligation to either recombinantly-
expressed protein thioesters in a process called expressed protein ligation (EPL) or to other 
chemically synthesized peptides via native chemical ligation (NCL) to create full-length 
modified histone proteins (16, 17). This strategy allows specific control of both the location and 
Figure 3. Schematic of ligation. 
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type of modification in each protein, but has typically been limited to in vitro study. 
A schematic of ligation is illustrated in Figure 3. The N-terminal piece must contain a C-
terminal α-thioester which can be introduced either recombinantly, through fusion with an intein 
in the expression plasmid and thiolysis following purification to reveal the thioester, or as part of 
the chemical synthesis of the peptide. The C-terminal piece must contain an N-terminal 1,2-
aminothiol, generally a cysteine. During ligation, the sulfur of the cysteine will replace the 
thioester sulfur by attacking the carbonyl and displacing the thioester in a transthioesterification 
process, creating a bond between the two pieces. This then undergoes a spontaneous acyl shift 
from the thioester to an amide bond with the nitrogen from the N-terminus. This reaction yields a 
full protein made from the two segments, with a native amide bond at the ligation junction (16, 
17).  
Ligation sites, of course, require a cysteine; however, the histone core contains only one 
cysteine. In these cases, ligation sites can be chosen at alanine residues. The cysteine can be 
desulfurized using a radical mechanism to reveal the native alanine (18). This technique can also 
be used with other residues such as glutamine (19), valine (20), leucine (21), and even proline 
(22). In these cases, N-terminal amino acid is a thiol-modified residue with a thiol group attached 
at the β-carbon.  
Developing Methods for In Vivo Study of Chemically-Modified Histones 
Chemical protein synthesis is extremely powerful but limits modification studies to an in vitro 
system. While in vitro studies have revealed many insights into the functions of histone 
modifications as they relate to chromatin structure and DNA processes, these experiments lack 
the complexity of native biological systems. There remains the need for tools introduce 
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exogenous, chemically-synthesized histones into a cellular environment to observe how 
specifically modified histones interact with the cellular machinery and thereby gain a greater 
understanding of their role.  
The slime mold Physarum polycephalum has been claimed to have a unique ability to uptake 
macromolecules, particularly histone proteins, from its external environment, most likely 
through an endocytotic or pinocytotic mechanism. Not only does this organism not break down 
exogenous histones, but it incorporates them into its own cellular processes (23, 24). We 
therefore hypothesized that P. polycephalum, then, may provide an opportunity to quickly and 
easily study synthetic proteins in vivo. In this thesis, we describe our progress towards this goal, 
and further, explore cell penetrating behavior of histones in multiple eukaryotic cells. 
In order to study histones in vivo in a eukaryotic system, they must be distinguished in some way 
from the native histones, as well as made easy to visualize via our analysis methods. In Chapter 
2, we discuss the techniques used for histone labeling. We introduce both fluorescent and affinity 
labels to histone proteins. Standard methods can be used to label histones with maleimide-
functionalized labels through alkylation of cysteines introduced through well-defined site-
directed mutagenesis. However, this approach is not compatible or efficient with protein semi-
synthesis and desulfurization. Instead, we developed an approach in which the N-terminal serine 
of either H2A or H4 is converted into an aldehyde which then serves as a labeling handle. This 
technique is compatible with recombinant, semi- and fully-synthetic histones and allows 
divergent labeling of a single protein preparation. Further, we demonstrate compatibility with 
maleimide labeling by the generation of a dual-labeled H2A with an N-terminal biotin attached 
through aldehyde introduction and a fluorescein added through cysteine alkylation. 
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In Chapter 3, we demonstrate uptake of exogenous histones into P. polycephalum. We further 
demonstrate transport of these proteins into nuclei, and specifically into chromatin. These results 
allow study of chemically-synthesized modified histones to be studied in the relevant and 
complex environment of the eukaryotic nucleus. 
In Chapter 4, we explore uptake of exogenous histones into a variety of eukaryotic cell models, 
based on the observation that the unstructured, positively charged tails of histone proteins 
resemble canonical cell penetrating peptides (25). We demonstrate histone uptake into a true 
mold of the Mucor genus as well as rat intestinal endothelial cells (IEC), human HeLa cells, and 
breast cancer MDA-231 cells. This allows histone PTMs to be studied in an increasingly relevant 
environment including mammalian cell lines and lays the groundwork for a better understanding 
of how these PTMs interact with a cellular environment and therefore of their function and cross-
talk with other modifications, which can provide insights into human disease such as cancer.  
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Chapter 2: Chemical Labeling Strategies for Histone Proteins 
Introduction 
In order to track exogenous histones once they enter a cell, they must be labeled in some fashion 
to distinguish them from the endogenous histones of that cell line. The most common approach 
in the literature is introduction of maleimide-functionalized labels at cysteines introduced by site-
directed mutagenesis in well-studied locations. This labeling technique works through alkylation 
of the side chain sulfur (see Fig. 4). This method is typically appropriate for nucleosomes since 
the only native Cys is H3-C110, which is typically removed. Common cysteine introduction sites 
include H2A-K119C and H3-V35C (5). Our laboratory commonly uses this approach to prepare 
bulk, labeled recombinant histone proteins, and several histones labeled by this approach are 
used throughout this work. This approach is sufficiently common that we do not include here any 
characterization of these molecules. 
Figure 4. . Maleimide labeling 
schematic. R represents the label. It 
can be a fluorophore such as 
fluorescein or a pull-down tag such 
as biotin. 
 11 
In spite of the advantages of this technique, maleimide labeling is generally unsuitable for semi- 
and fully-synthetic histones. The desulfurization step removes all cysteines from the protein after 
ligation, thereby removing the maleimide-reactive group. This problem can be overcome by 
synthesis of a label into one of the peptides, but this method requires production of a specific 
peptide and semisynthetic or fully synthetic protein for a single use. The number of required 
syntheses and ligations would therefore increase dramatically. Because production of synthetic 
proteins is costly and time-consuming, this approach is undesirable. Instead, we sought to 
develop a more creative labeling approach for semi- and fully-synthetic histones that is specific 
enough to label each protein only once, does not disrupt protein folding or interactions with other 
molecules, can be done under relatively gentle conditions, and which can introduce this diversity 
of labels into a single batch of prepared histone. We hypothesized that aldehyde labeling would 
provide this approach. 
Histones H2A and H4 have an N-terminal serine residue which is a 1,2-aminol with a primary 
amine (1), a relatively unique property within the cell. Sodium periodate can oxidize these 1,2-
aminols to create an N-terminal aldehyde moiety, making these proteins perfect candidates for 
specific labeling (schematic in Fig. 5).  The aldehyde can be derivatized with hydroxylamine or 
hydrazide functionalities, forming an oxime or a hydrazone bond respectively. This bond can 
then be reduced with NaBH4 to create an irreversible linkage between the label and the aldehyde-
converted molecule. (26, 27). Labeling using this technique allows wild type recombinant H2A 
and H4 to be labeled easily, and is further compatible with a semi-synthetic or fully-synthetic 
strategy for histone production. The ability to label both of these proteins using this method 
provides a means of introducing a label into both histone dimer and histone tetramer, the two 
 12 
complexes that make up the histone core of the nucleosome, allowing us to independently probe 
the relevant histone complexes.  
  
Figure 5. Schematic of N-terminal 
aldehyde conversion and labeling. R can be 
any label attached to a hydrazine group, 
and the hydrazine can be replaced with a 
hydroxylamine. 
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Results and Discussion 
Aldehyde labeling has been used across a number of biomolecules, but we required an approach 
that was compatible with histone proteins. We first tested a “one-pot” approach (27), in which all 
conversion and labeling reagents are added and allowed to react without first removing the 
Figure 6. MALDI-TOF analysis of biotin 
labeling of hH2A. A) 0 hr. hH2A: [M+H]
+
 
observed: m/z 13974, expected: m/z 13974; 
B) Aldehyde conversion. Ald-hH2A: 
[M+H]
+
 observed: m/z 13944, expected: m/z 
13942; C) Overnight biotin labeling. Biotin-
hH2A: [M+H]
+
 observed: m/z 14295, 
expected: m/ z 14297. 
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oxidizing agent. Figure 6 illustrates the reaction in which human H2A (hH2A) was treated with 
sodium periodate and labeled with biotinamidohexanoic acid hydrazide overnight at 4ºC. We 
found that, for labeling with a biotin hydrazide moiety, the one-pot reaction is sufficient, We also 
found that a 15-min pause after addition of periodate and before addition of the hydrazide label 
was required to fully convert the serine into an aldehyde.  
The one-pot reaction works efficiently for labeling of proteins and peptides with hydrazide and 
hydroxylamine compounds (data not shown for tests with O-(carboxymethyl)hydroxylamine). 
However, we found that thiosemicarbazide derivatives, such as the commercially available 
fluorescein thiosemicarbazide, reacted at multiple sites within the protein when carried out in the 
presence of unquenched periodate (Fig. 7). For these reagents, we developed a stepwise 
approach.  Here, the aldehyde conversion is first performed by treatment with 5mM periodate for 
15 minutes, then quenched with glycerol, which contains diols that react with the periodate. 
Since the glycerol is converted into glyceraldehyde, which would compete with the protein 
aldehyde for the label, it must be removed by overnight dialysis prior to the labeling. Addition of 
fluorescein thiosemicarbazide then results in a single label per protein molecule.  This is 
demonstrated with human H2A (hH2A) in Figure 8, but is also compatible with histone H4.  
Figure 7. ESI mass spectrometry analysis of one-pot fluorescein labeling of hH2A . Under 
these conditions, the protein is partially doubly-labeled: ald-hH2A: [M+H]
+
 observed: m/z 
13944, expected: m/z 13942; fl-hH2A: [M+H]
+
 observed: m/z 14346, expected: m/z 14345; 
doubly labeled hH2A: [M+H]
+
 observed: m/z 14731, expected: m/z 14732. 
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While labeling at an N-terminal aldehyde was successful across multiple reagents tested, we 
found that the resulting linkage was susceptible to hydrolysis, regenerating free label and 
aldehyde under the conditions required for our cellular assays for thiosemicarbazide, hydrazide, 
and hydroxylamine labeling reagents. As a solution, we chose to reduce the double bond by 
treatment with sodium borohydride to generate a stable linkage. To test the efficiency of the 
Figure 9. MALDI-TOF analysis of 
biotin labeling of N-terminal serine 
peptide. A) unlabeled; B) biotinylated. 
Expected and observed masses as 
noted in the figure ([M+H]
+
). The 
second highest peak in each spectrum 
is the sodium salt (+22 m/z). 
Figure 10. MALDI-TOF analysis of 
reduction of labeling. A) unreduced; B) 
reduced. The scale is expanded relative 
to Fig. 9 to show fine detail; unlabeled 
peaks are isotope distribution as 
expected for natural abundance. 
Expected and observed masses as noted 
in the figure ([M+H]
+
). The peaks near 
1300 m/z represent the sodium salt (+22 
m/z). 
Figure 8. ESI mass spectrometry analysis of step-wise fluorescein labeling of hH2A. The 
protein is  singly labeled  with fluorescein. Desired product fl-hH2A: [M+H]
+
 observed: m/z 
14349, expected: m/z 14346. Unlabeled product ald-hH2A: [M+H]
+
 observed: m/z 13944, 
expected: m/z 13942. 
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reduction, a short sample peptide (SVPFSRV-Dbz, named N-term Ser peptide) with an N-
terminal serine was synthesized, aldehyde-converted, biotin-labeled (Fig. 9), and reduced (Fig. 
10). The small molecular weight of the product allowed a resolution of 1 Da in MALDI-TOF MS 
analysis of the reaction, which was necessary for the evaluation because reduction of a double to 
single bond adds only 2 Da to the labeled peptide. We found that successful reduction with 
sodium borohydride first required removal of excess periodate by treatment with glycerol to 
quench the reagent (data not shown). After periodate removal, the labeled peptide was reduced 
with 50 mM sodium borohydride at 4 ºC overnight. Figure 9 shows MALDI-TOF assessment of 
one-pot biotin labeling of the peptide, illustrating successful aldehyde conversion and labeling. 
Figure 10 shows MALDI-TOF MS analysis before and after reduction overnight at 4 °C. 
Approximately 70% reduction was observed (assuming similar ionization properties). While 
further optimization would likely increase yields, this is sufficient for our purposes. 
In order to simultaneously attach an affinity label and an imaging probe, dual-labeled histones 
bearing both a biotin and a fluorescein simultaneously were required.  To further streamline this 
process, we used the one-pot approach on a refolded H2A/H2B dimer in which H2A was 
previously labeled with fluorescein-maleimide at H2A-K119C. Labeling a pre-folded complex 
would provide an improved workflow, in which readily available Fl-H2A could be refolded with 
H2B and immediately labeled prior to gel filtration purification, such that both misfolded 
complexes and excess label would be simultaneously removed.  This scheme is depicted in 
Figure 11. Characterization of the labeled product is shown in Fig. 12.  While MALDI-TOF MS 
as we carried it out is not fully quantitative, these results suggest that the dimer was 
predominantly dual-labeled.  However, we found that reduction and purification were 
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Figure 11. Schematic of double labeling of H2A/H2B histone dimer. 
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problematic in the context of the folded complex. Borohydride hydrolyzes water, evolving 
hydrogen gas in sufficient quantities to disrupt complex folding and as well as chromatography. 
After reduction of a single protein, we typically remove excess borohydride by dialysis (26) prior 
to refolding, and excess gas does not interfere. While labeling of the refolded complex is 
efficient and convenient, the best method of label introduction seems to be through labeling of 
Figure 12. MALDI-TOF analysis of biotin labeling of 
fl-hH2A/hH2B dimer. A) fl-dimer. hH2B: [M+H]
+
 
observed: m/z 13781 m/z expected: 13772; fl-hH2A 
[M+H]
+
 observed: m/z 14378, expected: m/z 14376; B) 
Biotin labeling of fl-dimer. hH2B: [M+H]
+
 observed: m/z 
13771; fl-hH2A: [M+H]
+
 observed: m/z 14379; sodium 
salt of biotinylated fl-hH2A: [M+H]
+
 observed: m/z 
14713, expected: m/z 14720; C) Biotinylated dimer 
purified by size exclusion: hH2B: [M+H]
+
 observed: m/z 
13774; biotinylated fl-hH2A: [M+H]
+
 observed: m/z 
14704, expected: m/z 14698.  
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unfolded, single proteins which can then be refolded into complexes. 
Conclusions 
We have developed efficient labeling schemes suitable for use with recombinant wild type 
histones. These approaches can be applied identically to H2A, H4 and semisynthetic and fully-
synthetic histones in the future for in cellulo study of histone post-translational modifications. 
We plan to use this technique to introduce fluorescent labels and affinity tags to H4. The 
fluorescent tags are necessary for cellular imaging, distinguishing between exogenous and 
endogenous histones in nuclear isolation experiments, as well as quantitation of protein uptake. 
The affinity tag will be used in pull-down assays to study cross-talk of H4 modifications in 
cellulo via recovery of introduced protein. 
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Chapter 3: Protein Uptake in Physarum polycephalum 
Introduction 
The myxomycete slime mold Physarum polycephalum has been shown to uptake exogenous 
proteins, particularly histone proteins, through an endocytotic or pinocytotic mechanism. Rather 
than degrading these proteins, it appears to incorporate them into its cellular machinery (23, 24, 
28). P. polycephalum has a complex life cycle with multiple different stages mediated by access 
to nutrients and light. We focus on the plasmodial life stage. In the plasmodial stage, P. 
polycephalum forms large multinucleated cells. In shaken liquid cultures, smaller 
microplasmodia are the predominant form, but when transferred onto solid medium, the 
Figure 13. Physarum polycephalum 
macroplasmodium. Photo Credit: Jerry 
Kirkhart, under Creative Commons License. 
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microplasmodia will coalesce into large macroplasmodia that can reach diameters of up to 14 cm 
(Fig. 13) (29). Within the first two cell cycles after coalescence, all the nuclei within one 
macroplasmodia have synchronous cell cycles (30). Thiriet et al. (2001) has shown not only that 
P. polycephalum uptakes histones into plasmodia but also that these histones are then 
incorporated into chromatin (31). This property has been used to study the role and importance 
of histone N-terminal tail regions and nucleosome exchange (24, 31, 32). We hypothesize that 
synthetic and semi-synthetic histones should be amenable to uptake by P. polycephalum. In this 
chapter, we describe optimization of histone uptake for chemically labeled and for semi-
synthetic histone proteins that will enable future study of the role of specific combinations of 
histone acetylation in vivo. 
Results and Discussion 
Prior to this work, the Ottesen Laboratory had not cultured eukaryotic organisms.  The first steps 
of this work were to develop culturing and handling protocols suitable to carry out uptake 
experiments. The copious work carried out in this area repeats published protocols, and is 
therefore not included in this document. Experimental protocols for generation and maintenance 
of both microplasmodial and macroplasmodial cultures suitable for uptake assays are fully 
described in Appendix A. 
Several parameters must be modulated for successful uptake of histone proteins.  First, we find 
that refolded histone complexes (H2A/H2B dimer, or H32/H42 tetramer) show superior uptake 
over individual unfolded histones which (data not shown) appear to precipitate nonspecifically in 
culture media.  Second, we find that media must be refreshed, and plasmodia washed, 
immediately prior to uptake to avoid degradation of protein samples by secreted proteases. Third, 
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for uptake, concentration of the sample is thought to be key; we maintain at least 1 μM histone as 
measured on the total complex (not individual histones) for optimal uptake, although some 
optimization remains to be carried out.  
Uptake in Microplasmodia 
We first validated uptake of folded histone complexes into P. polycephalum microplasmodia, 
using fluorescently labeled H2A/H2B dimer (fl-H2A-K119C/H2B, labeled using the maleimide 
method) and labeled H32H42 tetramer (fl-H3-V35C2/H42 tetramer, labeled using the maleimide 
method).  Each histone complex was introduced to the external media in microplasmodial 
cultures for 3 hours at a concentration of 1 µM. 
We carried out confocal microscopy of microplasmodia (Fig. 14), although imaging protocols 
were not optimal.  After uptake and washing, microplasmodia were visualized using both DIC 
and fluorescence confocal microscopy. The cells are brightly stained with the fluorophore while 
Figure 14. Confocal fluorescent microscopy of uptake in P. polycephalum. 3 hr uptake of 
fl-dimer and fl-tetramer in P. polycephalum microplasmodia. 
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the background remains entirely unstained, indicating that the protein entered the cell. As a 
control, microplasmodia subjected solely to uptake buffer and washing was also imaged, 
demonstrating that the organism itself does not display significant fluorescence at this 
wavelength. 
To further evaluate the intracellular distribution of exogenous histone, we developed a 
fractionation protocol to isolate cellular components, especially isolating the nuclei in which we 
anticipate finding exogenous histone.  Cells were harvested after imaging, and then lysed. Nuclei 
were isolated from lysis pellets using Percoll gradient purification (see Appendix A). Samples 
were analyzed by SDS-PAGE and visualized by fluorescent imaging via Typhoon scanner 
(Figure 15). The fluorescence in each fraction was evaluated by analysis with ImageQuant 
software (data not shown). As expected, significant fluorescence remains in the external media, 
since uptake is not expected to be complete. For both dimer and tetramer, fluorescence was 
distributed between the soluble and pellet fractions, suggesting histone is found in both the 
cytoplasm and the nucleus, although cellular membranes and slime are also found in the pellet 
Figure 15. SDS-PAGE analysis of the isolation of 
nuclei from the experiment shown in Fig. 13. Lanes: 1) 
external media; 2) soluble fraction; 3) lysis pellet; 4) 
Percoll sup; 5) isolated nuclei; 6) loading control 
representing 100% uptake of dimer or tetramer into one 
fraction. 
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fractions.  Therefore, the pellet was further purified to isolate nuclei, which contained significant 
fluorescence (Fig. 15, lane 5), which suggests that once the histones enter the cell, they are 
transported into the nucleus. 
Uptake into Macroplasmodia 
Microplasmodia can be grown in shaking culture and are convenient to work with, while 
macroplasmodia grow on a stationary solid surface (filter paper suspended over media). 
Therefore, microplasmodial cultures are more convenient to work with, but macroplasmodial 
samples also have some advantages. Since protein uptake is cell cycle dependent (24); one 
synchronous cell (macroplasmodium) at the right point in its cycle should exhibit higher uptake 
than many small cells at varying points.  We therefore validated uptake of histone dimer (fl-
H2A-K119C/H2B) into P. polycephalum macroplasmodia.  
Figure 16. Gel electrophoresis 
of fl-dimer uptake in 
macroplasmodia. 3 hour 
uptake in P. polycephalum 
macroplasmodia. Lanes: 1) 
external media; 2) soluble 
fraction; 3) lysis pellet; 4) 
Percoll sup; 5) isolated nuclei; 
6) loading control representing 
100% uptake of dimer into 
one fraction. 
Figure 17. Quantitative 
loading of Figure 16. 
Lanes 1-6 are the same 
as in Figure 16. 
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For uptake into macroplasmodia, microplasmodia are allowed to coalesce into one large 
macroplasmodium which is grown to 2-3 inch diameter.  Media is removed from the culture 
dish, but the surface is not washed.  Sample (400 μL of 1 μM complex) is pipetted over as broad 
as possible an area of the macroplasmodium surface and allowed to absorb for 3 hours.  Uptake 
was assessed by lysis and fractionation (Fig. 16 and 17). Uptake did not appear significantly 
greater than in microplasmodial assays, based on total internal fluorescence.  However, histone 
addition was also not timed to the cell cycle, which takes approximately 9 hours.  
In both microplasmodia and macroplasmodia we see some histone uptake, as well as 
incorporation into nuclei, after 3 h (Fig. 16, lanes 3 and 5). In macroplasmodia, some of the 
exogenous protein appears to be degraded in the media as assessed by the development of a 
lower band in all lanes.  These degradation products then appear to be taken up by the 
macroplasmodia.  This increase in visible degradation might be attributed to the location of our 
label, which is near the C-terminus of H2A rather than at the N-terminus; fluorescence would 
therefore be maintained in degradation products.  Very little fluorescence is observed in the 
media/wash after uptake.  This is most likely because of higher degradation of that protein rather 
than higher uptake, since the amount of fluorescence observed in the intracellular components 
does not add up to the equivalent of full uptake (lane 6 in Fig 16 and 17). This would not be 
surprising, since macroplasmodia typically secrete significant amounts of proteases into the 
slime layer, which is challenging to remove from the adhered plasmodium. In addition, 
quantitation is challenging in macroplasmodial cultures, due to the growth form. 
Overall, we found that macroplasmodial uptake may provide some benefits, but significantly 
more histone was required for each macroplasmodial uptake assay, and loading was difficult to 
control across the uneven cell surface. For the majority of our assays, we chose to continue in 
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microplasmodia.  
Uptake of Semisynthetic Histones 
We next sought to carry out the first uptake assay using semi-synthetic proteins. We selected 
semisynthetic H4 with acetylation at lysine 91 (H4-K91ac). H4-K91ac occurs at the tetramer-
dimer interface of the nucleosome core, and is thought to play an important role in chromatin 
assembly.  At the time of this assay, the N-terminal labeling approach had not been fully 
developed.  Therefore, fluorescent tetramer containing H4-K91ac refolded and fluorescein-
labeled H3 (introduced as a maleimide at H3V35C) was used for uptake into microplasmodia in 
shaken culture.  Of note, the fluorescein label is not on the semisynthetic histone in this assay; 
detection is therefore somewhat indirect – while we expect that H3 fluorescence will track with 
H4 localization, this co-localization has not been directly demonstrated.  
After 3 hr of uptake, cells were harvested, nuclei were isolated, and all cellular fractions were 
analyzed by SDS-PAGE with fluorescent imaging to track histone H3 (Fig. 18). Fluorescence is 
 
Figure 18. Uptake of H4-
K91ac fl-tetramer into P. 
polycephalum. Lanes: 1) 
external media; 2) soluble 
fraction; 3) lysis pellet; 4) 
Percoll sup; 5) isolated nuclei. 
 
H3 
1 2 3 4 5 
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observed in the soluble fraction (cytoplasm) and in isolated nuclei. Localization into the nucleus 
strongly suggests that these histones were also incorporated into chromatin, although isolated 
mononucleosomes were not directly observed. Taken together, this suggests the first uptake of a 
semisynthetic histone with a biologically relevant post-translational modification into a 
eukaryotic cell.   
Development of pull-down assays for exogenous histones introduced to P. polycephalum 
While fluorescent labels are sufficient to visualize the exogenous histones after uptake, 
downstream direct analysis of the incorporated histone requires a mechanism to recover the 
protein from the cellular context. We develop this with a dual labeling approach in which both 
fluorescein and biotin were simultaneously introduced to folded histone dimer, which allows 
avidin capture of the introduced dimer. To do this, we labeled H2A with fluorescein maleimide 
as described in Chapter 2. This fluorescent protein was refolded into H2A/H2B dimer, which 
was then labeled a second time with a biotin tag at the N-terminus of H2A using aldehyde 
conversion (see Fig. 11).  Histones are notoriously susceptible to avidin pull-down if rigorous 
 
Figure 19. Uptake of fl-H2A/H2B (left) and 
biotinylated fl-H2A/H2B (right). SDS-PAGE 
analysis of nuclear isolation. Lanes: 1) external 
media; 2) wash 1; 3) wash 2; 4) soluble fraction; 5) 
purified nuclei. 
1 2 3 4 5 1 2 3 4 5 
Fl-H2A/H2B Biotinylated fl-H2A/H2B 
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care is not taken to minimize interactions (33).  Therefore, significant optimization was carried 
out prior to this uptake assay. 
The folded, dual-labeled dimer was introduced to P. polycephalum microplasmodia for 3 hours 
of uptake. As a pull-down control, fluorescein-5-maleimide-labeled dimer lacking the biotin 
affinity tag was introduced to a second culture. After 3 hours of uptake, cells were harvested and 
nuclei were isolated and assessed by SDS-PAGE. Figure 19 illustrates that both fl-H2A/H2B 
(left) and biotinylated fl-H2A/H2B (right), were taken up by the microplasmodia and transported 
into the nuclei.  
The nuclei were lysed by sonication and treated with MNase to digest chromatin into individual 
mononucleosomes. Histones were pulled down onto magnetic beads coated with monomeric 
avidin in the presence of 20% glycerol and washed extensively.  Beads were analyzed by SDS-
PAGE with fluorescent imaging (Fig. 20).    Fl-biotin-H2A is observed on beads, but Fl-H2A in 
the absence of biotin was not (Fig. 20, each lane 5). This demonstrates successful pull-down of 
exogenous biotin-labeled histone as well as a lack of non-specific binding of Fl-H2A.  These 
pull-down assays will be further developed for total analysis of recovered mononucleosomes, as 
 
Figure 20. Avidin pull-down from isolated nuclei. 
Lanes: 1) input; 2-4) washes 1-3; 5) elution from 
beads. Left: biotinylated fl-H2A/H2B, right: fl-
H2A/H2B 
1 2 3 4 5 1 2 3 4 5 
Biotinylated fl-H2A/H2B Fl-H2A/H2B 
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well as further analysis of the retained biotinylated exogenous histone by mass spectrometry.  
Conclusions 
In this chapter, we demonstrate successful uptake of chemically labeled histones into P. 
polycephalum microplasmodia and macroplasmodia. These histones appear to be transported into 
nuclei, suggesting that they are deposited into chromatin. Together with the first successful 
introduction of an exogenous semisynthetic histone directly into a eukaryotic cell, these findings 
support P. polycephalum as a good system for in vivo study of synthetic modified histones to 
elucidate the functions of and cross-talk between histone modifications.  
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Chapter 4: Histone Uptake in Other Cell Lines 
Introduction 
There is some discrepancy in the literature as to whether histone uptake is a unique property of 
P. polycephalum. The highly positively charged, unstructured tails of histone proteins share 
some properties with cell-penetrating peptides. Taken together with an opportune culture error in 
which we observed histone uptake into a contaminant organism, these suggested that histone 
proteins might have cell penetrating properties that would allow uptake in higher order 
eukaryotic cells.  Here, we explore histone uptake in a variety of eukaryotic cells, culminating in 
successful uptake into mammalian and human cells. 
Results and Discussion 
Mucor 
By culture error, a contaminant organism was introduced to the P. polycephalum cultures early 
on in the project. Because it was introduced so early, and since the laboratory had no experience 
with the expected growth pattern and appearance of the slime mold, this error remained 
undetected for some time. As a result, histone uptake experiments were conducted on this 
organism. Interestingly, successful uptake was observed.  
In these assays, fluorescently-labeled histone dimer (fl-H2A-K119C/H2B, maleimide-labeled) 
was added to a shaken culture.  After 1 hour of uptake, fluorescence was observed in the soluble 
fraction of the cell and in some component of the lysis pellet (Fig. 21).  
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We immediately set out to identify the contaminant organism. Primers were designed to amplify 
the 18s ribosomal DNA. Because ribosomal DNA is relatively conserved between species, this 
technique allows primers that anneal to highly conserved regions to be used. At the same time, 
enough variations exist between ribosomes that the alignment results can provide information 
about the originating organism. Sequencing results are provided in Fig. 22, and alignment using 
BLAST, allowed the identity of the contaminant to be narrowed down to the Mucor genus, a 
collection of mold species that are common to the Ohio area. (34, 35). Mucor is a true mold that 
resides in soil, digestive systems, and plant material. It is a common laboratory mold and 
contaminant. Certain species of Mucor have been studied in depth as both pathogens and biofuel 
producers (35, 36).Slime molds, despite the name, are not fungal organisms but rather amoebal 
species.  True molds have many different qualities such as cell walls that would complicate 
protein uptake. No existing evidence suggests that any mold can uptake protein the way that P. 
Figure 21. Uptake of fl-dimer in 
Mucor. Time course of uptake into 
soluble and insoluble fractions over 
1 h. 1) media; 2) soluble fraction; 3) 
lysis pellet; DC) loading control 
representing 100% uptake into a 
single fraction. 
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polycephalum does. Regardless, histones appear to penetrate cells of the Mucor genus, a category 
of true molds.  
As a potential negative control, GFP (1 µM) was introduced to the true mold for 1 hr and 
analyzed by confocal fluorescent microscopy (Fig. 23). In the image, the edges of cells are 
lightly stained, but none of the fluorescence from GFP is found inside the cell. This implies that 
the protein is binding to the outside of the cells but not crossing the membrane, as would be 
expected for most proteins. This evidence supports the suggestion that import of histones into 
this organism is a unique property of histone proteins. We hypothesized that these proteins could 
also penetrate higher eukaryotic cells, possibly mediated by the unstructured, positively charged 
tails that resemble cell-penetrating peptides (CPPs). 
 
 
NNNNNNNNNNNNNNNNGCANNTNCGAAGATNTTCNNGCNNNNNAGGNCN
GNNNNNGANNANNTACANTGNTGNATNNNNNNNNNGNCTNGTATGGGGGT
GAGGACGGNGTAGCTCGNNNAACGACGATCCGTGGNCGTGNNNATCCGGT
GCTCTTTTGNGTGGATGCTTANGGTCCATACTTTGGCCATATCAAAGNTAGC
GATTTGCNNGGTTAATTNANTTTTAGTCTTTAGATGAGGTGGCCTGGTCTTC
NTTGATCAAGCTCGCTTTTATCGANACTTTTTTTCTGGTTATGCTATGAATA
GCTTCGGTTGTTTANAGTCNCTAGCCAGATGATTACCATGAGCAAATNAGA
GTGTTTAAAGCAGGCTTTCAAGCTTGAATGTGTTAGCATGGAATAATGAAA
TATGACTTTAGTCCCTATTTCGTTGGTTCAGGAACTTAAGTAATGATGAATA
GAAACGGTTGGGGACATTTGTATTTGGTCGCTAGAGGTGAAATTCTTGGAT
TGACCGAAGACAAACTACTGCGAAAGCATTTGATCCAGGACGTTTTCATTG
ATCAAGGTCTAAAGTTAAGGGATCGAAGACGATTAGATACCGTCGTAGTCT
TAACCACAAACTATGCCGACTAGAGATTGGGCTTGTTTATTATGACTAGCTC
AGCATCTTAGCGAAAGTAAAGTTTTTGGGTTCTGGGGGGAGTATGGGACGC
AAGGCTGAAACTTAAAGGAATTGACGGAAGGGCACCACCAGGAGTGGAGC
CTGCGGCTTAATTTGACTCAACACGGGGAAACTCACCNNTCCAGACATAGT
AAGGATTGACAGATTGAAAGCTCTTTCTAGATTCTATGGGTGGTGGTGCAT
GGCCGTTCTTAGTTCGTGNNCGATTNNNNGGGNTNANTANN 
 Figure 21. Sequencing results from PCR of 18s DNA. 
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Rat Intestinal Endothelial Cells 
We hypothesized that exogenous histones would successfully enter the cells of a higher 
eukaryote by exploiting the CPP-like properties of the histone tails. To test this, cultured rat 
 
Figure 23. GFP in Mucor. Fluorescent 
microscopy of cells after GFP uptake 
and washing. Note that the majority of 
the above-background fluorescence 
occurs at the perimeters of cells (arrow). 
 
Figure 24. Live fluorescence microscopy of Fl-H2A/H2B uptake 
in rat IEC cells: Left: Imaging on Hoechst. Right: Imaging on 
fluorescein. 
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intestinal endothelial cells were acquired from Dr. Elena Kudryashova (OSU). Fl-H2A-
K119C/H2B (1 μM) was added to adherant IEC2 cells, and  uptake was followed by live cell 
fluorescent microscopy for 3 hours (Fig. 24).  After 2.5 hours, fluorescence appeared to cluster 
co-localized with Hoechst stain, which suggested but did not demonstrate nuclear accumulation 
of fluorescent histone.   
After 3 hours, cells were harvested and nuclei were isolated. All cellular fractions were analyzed 
by SDS-PAGE and analyzed by fluorescent imaging (Fig. 25). The majority of the exogenous 
histones were split between the external media (lane 1) and the nuclei (lane 10), suggesting 
efficient transport and accumulation of the histones in the nuclei after uptake. Interestingly, 
while degradation bands are visible in the media, there appears to be little intracellular 
degradation. 
Live cell microscopy in HeLa cells  
Live cell fluorescence imaging was also used to visualize uptake of fluorescein-maleimide-
labeled dimer into cultured HeLa cells (also provided by Dr. Elena Kudryashova) (Fig. 26). First, 
 
Figure 25. Uptake of fl-dimer in adherent rat intestinal 
endothelial cells. Lanes: 1) external media; 2-5) PBS washes; 
6-8) supernatants from three consecutive lysis steps; 9) Percoll 
gradient supernatant; 10) isolated nuclei; 11) dimer control 
representing 200% uptake into a single fraction. 
 
1 2 3 4 5 6 7 8 9 10 11 
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labeled dimer was introduced to the surface of the adherent cells for 30 min, and the cells were 
thoroughly washed and imaged. Fluorescence was present in the cells while the background was 
dark, showing efficient uptake in only half an hour. Hoechst staining of nuclei shows 
colocalization of some of the fluorescein with chromatin. Punctate staining was highly evident, 
most likely representing fluorescent dimer encapsulated within endosomes. After washing, cells 
were followed for 2.5 h without further addition of histone.  Continued colocalization of some 
fluorescence with Hoechst stain for chromatin, mildly increased over background, suggests 
additional accumulation of histones in the nucleus over this time.  In addition, reduction in the 
punctate staining suggests that dimer is either degraded in endosomes, or escapes to reach the 
cytoplasm and the nucleus. This analysis is somewhat limited by the live cell microscopy 
because of its inability to distinguish between exogenous histones on the surface of nuclei and 
histones that have been transported into the organelle, as well as photobleaching of the 
fluorescein fluorophore with repeated imaging.  Confocal microscopy is required to truly 
Figure 26. Live fluorescence microscopy of Fl-H2A/H2B uptake in HeLa cells: Left: 
Imaging on Hoechst. Middle: Imaging on fluorescein. Right: Merged fluorescence. 
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demonstrate transport of histone proteins into the nucleus, which we demonstrate in MDA-231 
cells.  
MDA-231 Cells 
Human breast cancer MDA-231 cells were acquired (Dr. Michael Freitas, OSU Medical Center).  
Fl-H2A-K119C/H2B (maleimide-labeled) was added at a concentration of 1 µM and uptake was 
allowed to proceed for 1 hour.  Cells were thoroughly washed, fixed, and treated with Hoechst 
stain for comparison to chromatin.  Confocal microscopy was performed (CMIF), and cells were 
imaged on DIC, Hoechst, and fluorescein (Fig. 27).  
 
Figure 27. Confocal microscopy of fl-dimer uptake in human breast 
cancer MDA-231 cells. A) imaging on Hoechst; B) imaging on 
fluorescein; C) phase contrast; D) merged view. 
A B 
C D 
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Fluorescein (green) is clearly visible within the cell after one hour of uptake.  Further, there is 
clearly at least some colocalization of chromatin (Hoechst stain, blue) and fl-H2A (green), which 
demonstrates that histones are entering the nucleus, although perhaps not at high amounts.   
A clearer picture of the colocalization was obtained through a 3D reconstruction of each confocal 
 
 
Figure 28. 3D reconstruction of fl-dimer in human MDA-231  cells. Three different views of 
a 3D reconstruction of each layer of confocal microscopy. 
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layer. Figure 28 shows the same 3D reconstruction from three different angles. While some of 
the exogenous histone has entered nuclei after one hour of uptake, the majority remains in 
focused clusters, concentrated near the nuclear membrane and often in clefts pushed up against 
the nucleus. This suggests that dimer may localize to the golgi or the endoplasmic reticulum 
before being transported into the nucleus.  
Of note, these images were acquired after one hour of uptake, which is significantly shorter than 
the typical uptake assay carried out.  It would therefore not be unexpected for the histones to 
accumulate in an intermediate stage of transport.  Future plans include time course experiments 
to determine optimal uptake times, and to observe the transport pathway in these human cells. 
However, it is highly encouraging to see clear accumulation of histones in the nucleus, even at 
these early stages of uptake.    
Conclusions 
Our preliminary data suggests that histones are taken up by several different types of eukaryotic 
cells, and supports the hypothesis that the positively charged, unstructured histone tails act as cell 
penetrating peptides. This hypothesis spurred uptake experiments in rat IEC and human cancer 
cells. Analysis of histone uptake and incorporation into these cell lines shows not only cellular 
uptake but nuclear localization of the exogenous histones. Taken together, this implies that 
histone proteins display inherent cell-penetrating characteristics.  
While protein uptake and incorporation has been closely studied in P. polycephalum, a few 
studies have demonstrated histone uptake in higher cell lines as well. According to the literature, 
histone proteins penetrate the cell membranes of both plant protoplasts (37)  and of human 
cancer cells (38, 39), and that this uptake might be partially endocytosis-independent under the 
 39 
conditions used. However, these studies were also carried out using unfolded histone proteins 
which, in our hands, precipitate under the uptake conditions reported. It has also been suggested 
that covalent linkage of H2A to bovine serum albumin increased protein uptake (37-39).  
Taken together with our studies, these results suggest that histone proteins display cell 
penetrating characteristics, a property that would allow study of synthetic histones in mammalian 
or human cell lines. These systems provide studies with greater relevance, especially given the 
connection of histones and their modifications with cancer and other genetic diseases. 
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Chapter 5: Conclusions and Future Directions 
The goal of this project was to establish a means of easily introducing exogenous, chemically 
modified histone proteins into a eukaryotic cell. This uptake will permit study of chemically-
modified histones to move from in vitro analysis to in vivo experimentation. Interactions between 
the cell’s complex environment and the exogenous modified proteins can then provide a greater 
and more nuanced understanding of the functions of and crosstalk between histone PTMs. 
Successful incorporation of exogenous histones has been demonstrated in P. polycephalum 
microplasmodia and macroplasmodia, including the first demonstration of direct uptake of a 
semi-synthetic PTM-bearing histone protein by a eukaryotic cell. Not only do we observe uptake 
into whole cells but also incorporation into nuclei. We plan to conduct time courses of uptake in 
microplasmodia to determine the time at which the highest amount of exogenous histones are 
incorporated into the cell and into nuclei. A similar time course will be conducted in 
macroplasmodia with synchronous nuclei and monitoring of the cell cycle. This will be 
performed first to determine if histone uptake is cell cycle dependent and second to analyze 
possible advantages of uptake of histones into macroplasmodia at the correct point in the cell 
cycle over uptake into non-synchronous microplasmodia. We also aim to isolate 
mononucleosomes containing exogenous histones to directly demonstrate that histone proteins 
are not only transported into the nucleus of P. polycephlum but also deposited in chromatin. 
In addition to successful incorporation of exogenous histones into P. polycephalum, uptake was 
observed in higher order eukaryotic cell cultures. Incorporation of exogenous histones into 
fungal, mammalian, and human cells and nuclei suggests that histones display cell penetrating 
characteristics. This allows study of semi-synthetic and synthetic histone proteins with defined 
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sets of histone PTMs not only in an amoebal slime mold but also in mammalian and human cells, 
increasing the relevance of the discoveries made about the functions of these modifications. A 
time course of histone uptake in human cells is planned to study the temporal parameters of 
uptake of exogenous histones into cells and subsequent transport into nuclei. Confocal 
microscopy will be used to monitor this process to obtain the most accurate depiction of the 
process. Biotin pull-down techniques will also be developed for this system so that the 
introduced proteins can be recovered from the cellular environment. 
Our immediate plans are to use these combined techniques to determine the effect of H4-K91ac 
on intracellular histone transport, on chromatin deposition rate, and in modification crosstalk. 
This modification is located at the tetramer-dimer interface and has been shown to destabilize the 
nucleosome. Interestingly, it has also been found to be associated with the Hat1p-Hat2p-Hif1p 
chromatin deposition complex, indicating that it may be necessary for the incorporation of H4 
into the nucleosome, and has been implicated in acetylation of H4 at K5 and K12 (7). We will 
study this connection in vivo by comparing chromatin deposition of wild type H4 to that of the 
modified protein, produced by partial chemical synthesis of the protein. This will also be 
compared to chromatin deposition of H4-K91Q, where the lysine has been replaced by the 
acetyllysine mimic glutamine.  Other unpublished work in the laboratory has suggested that 
nucleosomes reconstituted with H4-K91Q have an intermediate stability between unmodified 
and H4-K91ac nucleosomes, but in a cellular context the most important difference might be that 
while H4-K91ac can be deacetylated and is thus a dynamic modification, H4-K91Q is static. 
Since chromatin maturation is associated with loss of H4-K91 acetylation, this difference may be 
important. 
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Secondly, we will look at the crosstalk between H4-K91ac and other modifications both on H4 
and throughout the nucleosome. Using the labeling technique discussed in Chapter 2, we can 
attach a biotin pull-down tag to the N-terminus of H4, allowing us to introduce the protein to a 
cell and then pull it back out. We can then analyze the protein to determine the modification 
state, or analyze a complex to determine binding partners. Since we can fractionate cytoplasmic 
fraction, nuclear fraction, and chromatin, this will allow us to characterize the binding partners 
and current modifications in a variety of contexts. These studies will be analyzed by mass 
spectrometry in collaboration with Dr. Michael Freitas to obtain a highly accurate 
characterization of the isolated molecules. Interestingly, we have found in preliminary studies 
that we can pull down entire mononucleosomes using a biotin-tagged histone, and then eliminate 
all but the tagged histone with high-salt washes, which will allow us for the first time to 
determine the dependence of the precise modification status of noncovalently linked histone 
proteins within a mononucleosome on the modification state of the probe protein.  This study 
will elucidate the way a cell responds to a histone with a specific set of modifications by 
changing that modification set and potentially reveal new functional relationships between 
histone modifications, and possibly of the so-called histone code. These studies open up entirely 
new directions in the study of epigenetic histone modifications in the context of the human cell.  
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Appendix A: Methods 
Cell Culture and Handling 
Generation and Handling of Physarum polycephalum Cultures 
SDM (semi-defined media): 17 mM citric acid, 0.3 mM FeSO4, 1.5 mM KH2PO4, 2.4 mM 
MgSO4, 0.4 mM MnCl2, 0.1 mM ZnSO4, 4 mM CaCl2, 10 mg/mL tryptone, 10 mg/mL glucose, 
1.5 mg/mL yeast extract, corrected to pH 4.6 with 6M HCl 
 
Hemin stock: 0.05% (w/v) hemin chloride in 1% NaOH 
 
All growth methods should be carried out using strict aseptic technique to prevent contamination 
with bacteria or mold strains. All pipette tips, beads, and filter paper should be autoclaved 
regularly. Fresh gloves should be worn, the benchtop and pipettes should be ethanol-sterilized, 
and a lit Bunsen burner should be nearby whenever cultures are handled. 
To start a plate from dried sclerotia, one piece of filter paper containing Physarum polycephalum 
(m3c) sclerotia is deposited face down on another filter paper suspended on glass beads in a petri 
dish. The bottom of the dish is filled with 12 mL of medium (1 mL of 0.05% hemin stock/100 
mL SDM). Plate cultures are incubated at room temperature (~22-25 °C) in a dark environment 
to prevent sporulation, refreshing the media periodically to allow continued growth. These 
cultures take between 3 and 7 days to cover the plate (24). 
When the culture has spread to cover the majority of the plate, it should be split to inoculate a 
new plate. To do this, a petri dish is prepared with beads, filter paper, and media. A scraping of 
the older culture is then transferred to the new plate with an ethanol-sterilized microspatula. A 
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plate culture can be grown from an inoculate from a liquid culture, but it requires a longer period 
of time before it begins to grow across the plate (24).  
For a liquid culture, 50 mL of media are inoculated with either a small scraping from a plate 
culture or 0.5 mL of a fully-grown liquid culture. Liquid cultures are incubated at 25 °C with 
shaking at 180 rpm. These cultures should be autoclaved twice before inoculation; once before 
addition of media and once after. A liquid culture takes between 3 and 7 days to reach workable 
density. A healthy liquid culture is identified by a high density of large, yellow microplasmodia 
surrounded by clear media. The presence of cloudy media and small microplasmodia indicates 
that the cell density is too high (24). 
Uptake in P. polycephalum microplasmodia and Mucor 
Microplasmodia from liquid culture were washed twice in fresh media to remove external, 
excreted proteases and resuspended in fresh media. Cells were centrifuged at 50g. Higher speeds 
may lead to premature cell lysis. Protein was added to 1 µM, and the cells were incubated for 3 
hours at 25°C with shaking in the dark.   Cells were then washed twice in wash buffer (20 mM 
Tris pH 7.5, 1 mM EDTA), resuspended in isolation buffer (15 mM Tris pH 8, 15 mM MgCl2, 5 
mM EDTA, 1 mM PMSF, 0.25 M hexylene glycol, 0.6% Triton X-100, 3 mM DTT), and 
sonicated for ten 1-second pulses at 70% amplitude.  Cells were then spun at 1,200g for 5 
minutes to separate the soluble fraction.  Uptake and analysis of Mucor cells followed this same 
technique.  
The pellet was then resuspended in 10 pellet volumes of 25% Percoll in isolation buffer and spun 
at 52,500g for 20 minutes.  The nuclei formed a visible ring near the bottom of the gradient. 
Isolated nuclei were washed three times in MNase digestion buffer (10 mM Tris pH 8.0, 60 mM 
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KCl, 15 mM NaCl, 1 mM CaCl2), and 1 U/µL MNase was added.  Samples were heated to 37°C 
for 5 minutes, and the MNase was quenched with 10 mM EDTA (40). Digested nuclei were then 
sonicated gently (5 x 1 sec, 70% amplitude) to break nuclei, freeing nucleosomes into the soluble 
portion after centrifugation at 1500g for 5 min. 
Uptake in P. polycephalum macroplasmodia 
Macroplasmodia can be generated from shaken cultures of microplasmodia. To do so, 50 mL of 
microplasmodia were centrifuged at 50g for 5 min, and the media was removed. The cells were 
washed with 10 mL of sterile water, resuspended in 1 mL of sterile water, and deposited on filter 
paper suspended on glass beads in media in a petri dish. The high density of the cells causes 
them to coalesce into a macroplasmodium. The macroplasmodium was allowed to grow to a 
diameter of 2-3 inches before uptake (24). 
Media was removed from the bottom of the dish prior to addition of exogenous protein. The 
protein solution (400 µL, 1 µM) was spread over as much of the surface of the 
macroplasmodium as possible. After the uptake time, the cell was soaked twice in 1 mM EDTA 
for 10 min each. It was then scraped off the filter paper and resuspended in isolation buffer. The 
mixture was homogenized to lyse the cell (10 gentle strokes) and then centrifuged at 1200g for 5 
min. Further lysate treatment is the same as with microplasmodia (24). 
Culture and Uptake in Mammalian Cells 
Rat IEC and HeLa cells were generously donated by the Kudryashov laboratory, and microscopy 
of these cells was performed using their live cell fluorescent microscope. Human MDA-231 cells 
were donated by the Freitas laboratory. Before addition of exogenous protein, cells were washed 
twice with PBS. Uptake in mammalian cells was performed identically to that in P. 
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polycephalum and Mucor for the time specified in the results. After uptake, cells were washed at 
least three times with phosphate buffered saline and centrifuged at 1000g for 10 min. The 
adherent cells were then trypsinized with TrypLE™ (Life Technologies) to remove them from 
the growth surface and then lysed with NP-40 buffer (10 mM Tris pH 7.5, 5 mM MgCl2, 10 mM 
NaCl, 0.5% NP-40). The lysis mixture was incubated on ice for 5 min then centrifuged at 500g 
for 5 min. Lysis was repeated 3x. Purification of nuclei followed the same protocol as isolation 
of nuclei from P. polycephalum (41). 
Microscopy 
To fix cells, they were first washed twice with wash buffer (20 mM Tris pH 7.5, 1 mM EDTA). 
Formaldehyde was added to the resuspended cells to 4% final concentration and incubated on ice 
for 15 min. The cells were then pelleted (50g, 5 min) and washed with wash buffer. To stain 
nuclei with Hoechst, the dye was added to the resuspended cells to 1 µg/mL final concentration 
and incubated on ice for 15 min. The cells were washed once more with wash buffer and plated 
on microscopy slides. Microscopy of P. polycephalum was performed using the confocal 
fluorescent microscope from the Hopper laboratory. Human MDA-231 microscopy was 
performed by the Campus Microscopy and Imaging Facility (CMIF). 
Biotin Pull-down 
Glycerol was added to digested nuclei to 20%. The mixture was then combined with magnetic 
monomeric avidin beads that had been washed with MNase digestion buffer. Proteins were 
allowed to bind for 10 minutes on ice. Beads were then washed (3 x 100 µL) in MNase digestion 
buffer + 10% glycerol (42). A small sample of beads was then run on a gel to ensure pull down.  
To elute from beads for SDS-PAGE analysis, a small sample of beads were boiled in SDS 
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loading dye for 5 min. Beads were pelleted before loading. To elute from the beads for mass 
spectrometry purposes, the beads were soaked in 5% formic acid for 15 minutes on ice.  These 
samples were then lyophilized to dryness.  
PCR of rDNA 
Cells of the unknown organism in liquid culture were lysed by heating at 100ºC in the presence 
of 5 mM phenylmethylsulfonylfluoride (PMSF) for 5 min. The lysate was then centrifuged at 
3000g for 10 min. The supernatant was then used as the template in a polymerase chain reaction 
using a forward primer with the sequence 5`-CCGGAGAAGGAGCCTGAGAAAC-3` and a 
reverse primer with the sequence 5`-AATTAAGCAGACAAATCACT-3`. Denaturation was 
completed by heating the reaction at 95ºC for 30 s. Annealing was carried out at 50ºC for 30 s. 
Polymerization was catalyzed by PFU at 72ºC for 1 min. The cycle was repeated 30 times. The 
PCR product was sequenced by the Ohio State Unversity Plant-Microbe Genomics Facility. 
Alignment was analyzed using BLAST technology (34). 
N-terminal Serine Labeling  
Label Introduction 
To convert the N-terminal serine into aldehyde, the protein (resuspended in 100 mM phosphate 
buffer pH 6) was incubated with 5 mM NaIO4 in for 15 minutes at 4°C.  Excess periodate was 
then quenched by incubating with 15 mM glycerol for 15 min at 37°C. Buffer exchange was 
performed on the reaction using the same phosphate buffer to remove the glyceraldehyde product 
which would interfere with the labeling. To label the aldehyde-containing protein, 5 mM 
biotinamidohexanoic acid hydrazide or 1 mM fluorescein-5-thiosemicarbazide was added. The 
reaction was allowed to nutate overnight at 4°C (26, 27).  
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Reduction of Linkage 
To reduce, NaBH4 was added to a final concentration of 50 mM (in 100 mM phosphate buffer 
pH 6) and the reaction was incubated on ice overnight. The reaction should not be capped 
because the borohydride will produce low amounts of hydrogen gas in water. To ensure 
quenching of the borohydride, 1M HCl was added until bubbles subsided. The reaction was then 
dialyzed into water overnight at 4°C. Extent of ligation and reduction were analyzed by MALDI-
TOF mass spectrometry (43). 
Recombinant and Semisynthetic Histones  
Fmoc Synthesis and Purification 
The C-terminal region of H4 (AKRKTVTAMDVVYALK(ac)RQGRTLYGFGG)  was 
synthesized using standard Fmoc protection strategies, using 2-(6-Chloro-1H-benzotriazole-1-
yl)- 1,1,3,3-tetramethylaminium hexafluorophosphate (HCTU) and diisopropylethylamine 
(DIEA) activation on pre-loaded Gly-Wang resin (Novabiochem) (44).  Synthesis was performed 
on an Aapptec Apex 396 synthesizer. The N-terminal alanine was coupled as a Boc-thiazolidine 
residue, in order to protect the cysteine during synthesis.  Acetyl-lysine, as Fmoc-Lys(Ac)-OH, 
and Fmoc-Lys(Alloc)-OH were purchased from Novabiochem and coupled normally. Alloc 
deprotection was done by swelling resin in CH2Cl2, and adding phenylsilane (20 eq) and 
tetrakis(triphenylphosphine) palladium (0.35 eq) and nutating 30 minutes.  Nbz conversion was 
performed by swelling resin in CH2Cl2, and adding p-nitrophenyl chloroformate (5 eq) followed 
by nutation for 45 minutes.  Resin is then washed into dimethylformamide (DMF) and rinsed 
with 0.5 M DIEA for 15 minutes (45). Peptides were cleaved from the resin by nutating at 25ºC 
for 3 h in 94% TFA, 2.5% ethanedithiol, 2.5% H2O, and 1% triisopropylsilane. After completion, 
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the cleavage solution was collected and concentrated under a nitrogen stream.  The cleaved 
peptide was then precipitated with diethyl ether (10 eq), centrifuged, and separated from the 
supernatant.  Thiazolidine ring opening to reveal the N-terminal cysteine was performed using 
0.4M methoxylamine, 50mM HEPES pH 7.5 for 4 hours, and confirmed by analytical C18 RP-
HPLC and MALDI-TOF mass spectrometry.  The peptide was then purified using C18 RP-
HPLC, using a gradient of Buffer B (90% acetonitrile and 0.1% trifluoroacetic acid (TFA) in 
water) in Buffer A (0.1% TFA in water). Pure pools were assessed by MALDI-TOF mass 
spectrometry and analytical C18 RP-HPLC. Pure samples were then lyophilized to dryness.   
Thioester Expression 
The truncated H4(1-75) was cloned into the pTXB1 plasmid and fused to the Mxe GyrA intein-
Chitin Binding domain using standard cloning techniques. The plasmid was then transformed 
into E.coli BL21 (DE3) competent cells. Protein was overexpressed at 37ºC in LB media with 
0.1 mg/mL ampicillin and induced at OD600 = 0.4 by addition of isopropyl β-D-1-
thiogalactopyranoside (IPTG) to 1 mM final concentration for 3 h before harvesting by 
centrifugation (17).  
Extraction from Inclusion Bodies 
Cells were resuspended in 10 – 25 mL lysis buffer (25 mM HEPES pH 7.5, 1 mM EDTA, 1M 
NaCl, 1 mM PMSF) and lysed by sonication. After centrifucation at 20,000g for 15 min at 4 ºC, 
the thioester-containing pellet was separated from the supernatant. The pellet was washed twice 
in 25 mL of Triton wash buffer 25 mM HEPES pH 7.5, 1 mM EDTA, 1 M NaCl, 1% Triton X-
100). The mixture was shaken for 20 min then centrifuged at 10,000g for 10 min at 4ºC and the 
supernatant was discarded. The pellet was washed in the same way in 25 mL of wash buffer 
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(Triton wash buffer without Triton X-100). DMSO (250 µL) was added to the pellet which was 
then minced with a spatula. This mixture was allowed to soak at 25 ºC for 30 min. The pellet was 
shaken in 30 mL of HU-500 buffer (6M urea, 25 mM HEPES pH 7.5, 1 mM EDTA, 500 mM 
NaCl) for 1 h to extract histones from the pellet then centrifuged at 15,000g for 10 min at 25 ºC. 
The supernatant was saved. This step was repeated without the DMSO soak. Extent of 
expression and extraction from inclusion bodies was evaluated by SDS-PAGE. Fractions 
containing thioester were pooled and either dialyzed against HU-100 (HU-500 with 100 mM 
NaCl) or diluted with HU-0 to reach 100 mM NaCl (17).  
Thioester Purification 
The dialyzed extract was purified by ion exchange over an SP-FF column (GE) by performing a 
gradient from HU-300 to HU-1000. Purified proteins were then refolded by dialysis into high 
salt buffer (25 mM HEPES pH 7.5, 1 mM EDTA, 1 M NaCl).  Thiolysis was initiated by 
addition of 100 mM 2-mercaptoethane sulfonate (MESNA), and allowed to cleave overnight at 
4°C.  After cleavage, buffer components were adjusted to ligation conditions (6 M urea, 25 mM 
HEPES pH 7.5, 1 M NaCl, 1 mM EDTA, 50 mM MESNA) and then concentrated. The extent of 
cleavage was analyzed by SDS-PAGE (17). 
Ligation 
Purified thioester was first treated with 5mM tris(2-carboxyethyl)phosphine (TCEP), and then 
used to resuspend 2.2 molar equivalents of pure C-terminal modified peptide.  After each 
addition pH was checked using pH strips. Ligation was allowed to proceed until complete as 
measured by SDS-PAGE gels. Ligation was generally completed after 8 hours.  When ligation 
was completed, the sample was desulfurized to convert the cysteine residue at the ligation site 
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into the native alanine. An equivalent volume of 6M guanidine-HCl, 50mM HEPES pH 7.5, and 
800mM TCEP was added to the sample which was then sparged with argon for 30 min. Reaction 
was initiated by the addition of VA-044US to 10mM and incubation at 42°C for 4 hours. Extent 
of desulfurization was determined by MALDI-TOF mass spectrometry. The sample was then 
purified using RP-HPLC, and pure samples were determined by MALDI-TOF mass 
spectrometry and SDS-PAGE.  Pure pools were then lyophilized to dryness (17). 
Recombinant Histone Expression and Purification 
Wild-type recombinant histones from Homo sapiens were expressed and purified as previously 
described for thioesters through ion exchange chromatography. After this purification step, 
histone proteins were further purified by RP-HPLC. Pure samples were determined by MALDI-
TOF spectrometry and pure pools were lyophilized to dryness.  H3C110A, H4-K91Q, H2A-
K119C, and H2A.Z I118C point mutations were created by site-directed mutagenesis 
(Stratagene) (17).  
Histone Refolding 
 For the refolding of histones, tetramers made up of H3C110A and WT H4, H4-K91ac, or H4-
K91Q, and dimers made up of H2A(K119C)-Flourescein and H2B or H2A.Z(I118C)-TAMRA 
and H2B were mixed in equal molar ratios.  The histones were dissolved in 6M Gdn-HCl, 25mM 
Tris pH 7.5, 1mM EDTA, and placed into engineered dialysis membranes and double dialyzed 
into 2M NaCl, 25mM Tris pH 7.5, 1mM EDTA.  Refoldings were then purified by size-
exclusion chromatography using a Superdex 200 10/300 GL column (GE Healthcare) using 2M 
NaCl, 25mM Tris pH 7.5, 1mM EDTA.  The labeling of histones was done as previously 
described. Briefly, unfolded protein was resuspended in denaturing buffer at neutral pH and 
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purged under argon atmosphere. It was then incubated in the presence of TCEP to ensure that the 
cysteines were in a reduced state. Maleimide label, in dimethylformamide, was added dropwise 
until a final concentration of about 20 equivalents was reached. The reaction was allowed to 
proceed for 5h at 25°C and then quenched with DTT (5).  For refoldings that are to be labeled by 
the aldehyde conversion, the Tris buffer is replaced with 50mM sodium phosphate pH 6.0.  
Reconstitution and Sucrose Gradient Purification 
DNA Constructs 
For the high affinity nucleosome positioning 601 sequence (46), the following primers were 
used, 5’CTGGAGSSTCCCGGTGCCGAGGC that contained a Cy5 flourescent label for tracer 
DNA and did not for bulk DNA, and 5’ACAGGATGTATATATCTGACACGTGCC. All PCRs 
were purified by HPLC using a Gen-Pak Fax column (Waters) and a gradient from TE-0 (20 mM 
Tris pH 7.5, 1 mM EDTA) to TE-1000 (20 mM Tris pH 7.5, 1 mM EDTA, 1 M NaCl).   
Reconstitution 
Purified tetramers, dimers, and DNA were mixed at a 1:2.2:1.1 molar ratio, unless otherwise 
noted, and dialyzed using engineered dialysis membranes into 25mM Tris pH 7.5, 1mM EDTA 
(47).  These nucleosomes were then sucrose purified using a 5-35% sucrose gradient, spun at 
288,000g for 22 hours. Fractions were analyzed by Native-PAGE.  Gels were scanned on a 
Typhoon Imager (GE) and quantitation was done in ImageQuant.  Pools were then concentrated, 
and concentration was determined by Nanospec UV absorbance at 280nm. 
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